NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

4/A - MBX Biosciences, Inc.

Filed: 2026-04-22 AccNo: 0001193125-26-168530 Size: 5 KB
发布时间04/22 12:02 UTC
首次发现04/22 12:07 UTC
热度106.2
重要度74
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 419 字符

Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] SEC Accession No. 0001193125-26-168530

Filing Date: 2026-04-22

Accepted: 2026-04-22 08:02:02

Documents: 1

Period of Report: 2025-11-22

Hoerter Steven L. ( Reporting ) CIK : 0001533451 (see all company filings) Type: 4/A | Act: 34 | File No.: 001-42272 | Film No.: 26881325

1 | 4/A | ownership.html | 4/A

1 | 4/A | ownership.xml | 4/A

同簇相关文章

从当前文章回到同一事件簇里的其他来源或补充材料。
1